Novavax says Covid-19 vaccine shows 90.4% overall efficacy in US/Mexico Phase 3 trial

The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Pha...

Posted: Jun 14, 2021 2:02 PM
Updated: Jun 14, 2021 2:15 PM

The American biotechnology company Novavax announced on Monday that its coronavirus vaccine candidate was found to have an overall efficacy of 90.4% in a Phase 3 trial conducted across the United States and Mexico.

Additional analyses of the trial are ongoing, according to the company, and will be submitted to peer-reviewed journals for publication.

The trial results appear consistent with the efficacy and safety profile the vaccine previously showed in a Phase 3 trial conducted in the United Kingdom, Dr. Gregory Glenn, president of research and development for Novavax, told CNN.

"Different continent, different population, different viruses floating around, and yet, we still see really good efficacy," Glenn said. "This is what you want to have."

The study launched in December and enrolled 29,960 adults across 113 sites in the United States and six sites in Mexico. Some of the participants were given a placebo and some were administered two doses of the Novavax vaccine 21 days apart.

The company said the vaccine was "generally well-tolerated" and common side effects included pain at the injection site, lasting less than three days, and fatigue, headache and muscle pain, lasting less than two days.

There were 77 Covid-19 cases that emerged among participants during the study, according to Novavax. Sixty-three of the cases were in people in the placebo group and 14 in the vaccine group.

The company noted that all cases in the vaccine group were mild. There were 10 moderate and four severe cases in the placebo group, demonstrating a vaccine efficacy of 100% against moderate or severe disease, according to Novavax.

Most cases were in "high-risk" people, such as those older than 65, with certain comorbidities or having frequent exposure to Covid-19. The company announced the vaccine's efficacy was 91% in "high-risk" populations.

Novavax researchers also took a close look at sequencing data for 54 of the 77 Covid-19 cases in the study. Based on their sequencing of those cases, the company announced that the "vaccine efficacy was 93.2%" against variants of concern or of interest.

A final analysis of Novavax's UK Phase 3 trial results, announced in March, showed that the vaccine had an overall efficacy of 89.7% -- and its efficacy was 96.4% against the original coronavirus strain and 86.3% against the B.1.1.7 variant first identified in the UK.

Novavax's coronavirus vaccine, called NVX-CoV2373, differs from the three vaccines already in use in the United States. The vaccine relies on what is called recombinant nanoparticle technology and Novavax's adjuvant, called Matrix-M, to stimulate an immune response.

The two mRNA vaccines that were authorized last year in the United States -- from Pfizer/BioNTech and Moderna -- both use genetic material to stimulate an immune response. Johnson & Johnson's single-shot vaccine, which was authorized in February, uses a weakened common cold virus as a vector to carry the genetic instructions.

Novavax said on Monday it plans to apply in the US for emergency use authorization of its vaccine in the third quarter of this year and is "on track" to manufacture about 100 million doses per month by the end of the third quarter.

New York Coronavirus Cases

County data is updated nightly.

Cases: 2408593

Reported Deaths: 55188
CountyCasesDeaths
Kings32093610760
Queens30738910177
Suffolk2296953526
Nassau2080873261
Bronx2029976705
New York1628104607
Westchester1413352329
Erie1000941888
Richmond862711908
Monroe789431158
Orange54975887
Rockland51151769
Onondaga46663723
Dutchess34029490
Albany28778370
Oneida26228554
Niagara22399386
Broome22200387
Saratoga18656191
Ulster16501273
Schenectady15473217
Rensselaer13522155
Putnam1194196
Chautauqua11235158
Oswego9920103
Chemung9354146
St. Lawrence9114119
Steuben8697160
Ontario8669100
Cayuga8034104
Sullivan789782
Jefferson764071
Wayne712878
Cattaraugus684999
Genesee6195131
Herkimer6102118
Tompkins607159
Clinton586634
Madison551598
Fulton545298
Livingston528967
Montgomery5213134
Cortland490871
Warren478478
Columbia4727109
Tioga450567
Chenango425986
Otsego422151
Allegany409193
Washington405865
Greene402483
Wyoming396454
Orleans375684
Franklin367016
Lewis326536
Delaware314241
Seneca251459
Schoharie210920
Essex200029
Yates142426
Schuyler132116
Hamilton4093
Unassigned12929
Out of NY0296
Utica
Cloudy
71° wxIcon
Hi: 71° Lo: 50°
Feels Like: 71°
Oneonta
Partly Cloudy
68° wxIcon
Hi: 73° Lo: 50°
Feels Like: 68°
Herkimer
Mostly Cloudy
71° wxIcon
Hi: 73° Lo: 49°
Feels Like: 71°
Old Forge
Cloudy
71° wxIcon
Hi: 62° Lo: 47°
Feels Like: 71°
WKTV Radar
WKTV Temperatures
WKTV Severe Weather
NEW Game Day Deals each week
Follow the 2021 Go the Distance Team - sponsored by Gilroy Kernan & Gilroy
Cool To Be Kind 2021
Chapter Photofacial Therapy Giveaway
Looking for work or looking to hire? Check out the WKTV Job Fair!
Saluting Those Who Are Proud 2 Serve